PERJETA pertuzumab (rch) 30mg/mL concentrate injection vial

Roche Products Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 052ac70624b12901
Product Name: PERJETA pertuzumab (rch) 30mg/mL concentrate injection vial
Artg Id: 196218
Artg Name: PERJETA pertuzumab (rch) 30mg/mL concentrate injection vial
Sponsor: Roche Products Pty Ltd
Company Detail Path: /organization/roche-products-pty-ltd
Artg Date: 2013-05-06
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2013-CMI-01653-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2013-PI-01655-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

052ac70624b12901

Type

Standard